Spiriva Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium and Olodaterol (Tio+Olo);   Drug: Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS) Sponsor:   Boehringer Ingelheim Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2019 Category: Research Source Type: clinical trials